News

Beleaguered Belgian biotech Galapagos said yesterday that its CEO, Paul Stoffels, plans to retire upon the appointment of his ...
In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...
Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...
but a clean one that is printable and updated. And this is where you'll get it now that we have officially reached the second weekend of the Big Dance. You know you want it. You know you need need ...
A group of five scientists who played key roles in the development of the widely successful weight-loss medications Ozempic and Wegovy have been awarded a $3-million Breakthrough Prize — one of the ...
32,625 people played the daily Crossword recently. Can you solve it faster than others?32,625 people played the daily Crossword recently. Can you solve it faster than others?
Semaglutide is available as Wegovy and Ozempic injections, and also as Rybelsus tablets. The study's findings indicate a potential link between these medications and a lower risk of dementia.
The drug semaglutide, found in popular brands like Wegovy and Ozempic, looks especially promising in lowering the chances of memory problems, a hallmark of dementia. The study looked at nearly ...
HYDERABAD (Reuters) - Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with rival Eli Lilly in the populous nation, two ...
In January, they were overtaken by Novartis’ Pluvicto and Johnson & Johnson’s Tremfya; last month, it was Novo Nordisk’s Wegovy and J&J’s immunology med that leapfrogged over the previous ...